Predictive and Prognostic Role of PD-L1 in Urothelial Carcinoma Patients with Anti-PD-1/PD-L1 Therapy: A Systematic Review and Meta-Analysis
Recently, checkpoint inhibition of the PD-1/PD-L1 axis has been shown to be therapeutically relevant in urothelial carcinoma (UC). To evaluate the predictive and prognostic value of PD-L1 on response and survival in UC patients after cystectomy, chemotherapy, or anti-PD-1/PD-L1 therapy, a systematic...
Main Authors: | Haoran Liu, Tao Ye, Xiaoqi Yang, Peng Lv, Xiaoliang Wu, Hui Zhou, Hongyan Lu, Kun Tang, Zhangqun Ye |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2020/8375348 |
Similar Items
-
Progress in the treatment of Bladder Urothelial Carcinoma with PD-1 / PD-L inhibitor
by: Tao Zhang, et al.
Published: (2019-04-01) -
Clinicopathological and prognostic value of PD-L1 in urothelial carcinoma: a meta-analysis
by: Ding X, et al.
Published: (2019-05-01) -
PD-L1 blockade for urothelial carcinoma
by: Josephine Kang, et al.
Published: (2017-07-01) -
Role of a Modified Urothelium Immune Prognostic Index in Patients With Metastatic Urothelial Carcinoma Treated With Anti–PD-1/PD-L1–Based Therapy
by: Haifeng Li, et al.
Published: (2021-08-01) -
The prognostic significance of PD-L1 and PD-1 expression in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis
by: Zi-Lu Huang, et al.
Published: (2019-05-01)